Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1
Danúbia Silva dos Santos(Universidade Federal do Rio de Janeiro), Adriana C. C. Girardi(Universidade de São Paulo)
Cited by 14
Related Papers
Angiotensin II counteracts the effects of cAMP/PKA on NHE3 activity and phosphorylation in proximal tubule cells
|American Journal of Physiology-Cell Physiology|2016|36
Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure
|Frontiers in Physiology|2016|20
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
|Stem Cell Research & Therapy|2018|19
Proximal tubule NHE3 activity is inhibited by beta-arrestin-biased angiotensin II type 1 receptor signaling
|American Journal of Physiology-Cell Physiology|2015|17